With the aim to increase the statistical value of antigen-specific repertoire analyses and to smooth individual variations, we analyzed TRAV and TRBV usage of all the Melan-A and MELOE-1 clonotypes (originating respectively from 6 and 4 HLA-2 metastatic melanoma patients). Here, MLANA is linked to metastatic melanoma.